Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Monath

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
The American Journal of Tropical Medicine and Hygiene|October 14, 2006
Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE)Mark Reid, Donna Mackenzie, Andrew Baron, et al.
The American Journal of Tropical Medicine and Hygiene|February 20, 2004
Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reactionBarbara W Johnson, Trudy V Chambers, Mary B Crabtree, et al.
Human Vaccines|October 3, 2006
Yellow fever 17D vaccine safety and immunogenicity in the elderlyThomas P Monath, Martin S Cetron, Karen McCarthy, et al.
Journal of Virology|October 28, 2004
ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacyJuan Arroyo, Chuck Miller, John Catalan, et al.
The Lancet. Infectious Diseases|December 25, 2016
Epidemic arboviral diseases: priorities for research and public healthAnnelies Wilder-Smith, Duane J Gubler, Scott C Weaver, et al.
Virology|February 17, 2007
A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirusCaroline C Maier, Simon Delagrave, Zhen-xi Zhang, et al.
The New England Journal of Medicine|April 8, 2011
An inactivated cell-culture vaccine against yellow feverThomas P Monath, Elizabeth Fowler, Casey T Johnson, et al.
The Journal of Infectious Diseases|September 20, 2005
Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functionsGetahun Abate, Joy Eslick, Frances K Newman, et al.
Vaccine|December 17, 2008
Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adultsSharon E Frey, Frances K Newman, Jeffrey S Kennedy, et al.
Emerging Infectious Diseases|December 25, 2002
Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster modelRobert B Tesh, Juan Arroyo, Amelia P A Travassos Da Rosa, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
The American Journal of Tropical Medicine and Hygiene|October 14, 2006
Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE)Mark Reid, Donna Mackenzie, Andrew Baron, et al.
The American Journal of Tropical Medicine and Hygiene|February 20, 2004
Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reactionBarbara W Johnson, Trudy V Chambers, Mary B Crabtree, et al.
Human Vaccines|October 3, 2006
Yellow fever 17D vaccine safety and immunogenicity in the elderlyThomas P Monath, Martin S Cetron, Karen McCarthy, et al.
Journal of Virology|October 28, 2004
ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacyJuan Arroyo, Chuck Miller, John Catalan, et al.
The Lancet. Infectious Diseases|December 25, 2016
Epidemic arboviral diseases: priorities for research and public healthAnnelies Wilder-Smith, Duane J Gubler, Scott C Weaver, et al.
Virology|February 17, 2007
A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirusCaroline C Maier, Simon Delagrave, Zhen-xi Zhang, et al.
The New England Journal of Medicine|April 8, 2011
An inactivated cell-culture vaccine against yellow feverThomas P Monath, Elizabeth Fowler, Casey T Johnson, et al.
The Journal of Infectious Diseases|September 20, 2005
Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functionsGetahun Abate, Joy Eslick, Frances K Newman, et al.
Vaccine|December 17, 2008
Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adultsSharon E Frey, Frances K Newman, Jeffrey S Kennedy, et al.
Emerging Infectious Diseases|December 25, 2002
Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster modelRobert B Tesh, Juan Arroyo, Amelia P A Travassos Da Rosa, et al.
Pageof 14